FibroBiologics raises ~$1.7M in registered direct offering at $0.33/share with warrants

FibroBiologics, Inc.

Sold 5,227,275 shares at $0.33/share; gross proceeds ~$1.7M; closing expected Dec 16, 2025.
Concurrent private placement of warrants to buy 5,227,275 shares at $0.33, exercisable only after stockholder approval, 5-year term.
CEO and prior purchaser entered voting agreements to support warrant share issuance under Nasdaq rules.
Placement agent H.C. Wainwright receives 7% cash fee and 365,909 warrants at $0.4125 per share.
Net proceeds for working capital and general corporate purposes.

item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.